Skip to main content
All lobbying filings

LIVANOVA USA, INC.

Lobbying for LIVANOVA USA, INC.

 Filing 4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$140,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Texas

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Medicare/Medicaid

Issues related to Medicare beneficiary access to treatments for depression and epilepsy. Issues related to Medicare beneficiary access to procedures performed in ambulatory surgical centers. Issues related to Medicare Prior Authorization.

Health Issues

Issues related to epilepsy. Issues related to telehealth.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem